Insider sale
DYNE THERAPEUTICS, INC.
$383.0K
21.93K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND II, L.P. plans to sell 21.93K shares of DYNE THERAPEUTICS, INC. valued at approximately $383.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/6/2026ACC: 0001628280-26-031383
10% Owner
Since Dec 2022
21.93K
Shares to sell
$383.0K
Approx. market value
21.93K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
12/12/2022
21.93KTotal acquired21.93K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2022 | Private Placement Cash | 21.93K | — |
| Total | 21.93K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
21.93K
Market value
$383.0K
5/6/2026
Total
Units
21.93K
Value
$383.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/6/2026 | 21.93K | $383.0K | Nasdaq | Planned |
| Total | 21.93K | $383.0K | ||